C44H46FN9O4 — CID 174216451
5-tert-butyl-N-[[4-[6-[4-[[4-[4-[(2,6-dioxopiperidin-3-yl)amino]-2-fluorophenyl]piperidin-1-yl]methyl]phenyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl]-2-methylphenyl]methyl]-1,2,4-oxadiazole-3-carboxamide (PubChem CID 174216451) has the molecular formula C44H46FN9O4 and a molecular weight of 783.91 g/mol. Its IUPAC name is 5-tert-butyl-N-[[4-[6-[4-[[4-[4-[(2,6-dioxopiperidin-3-yl)amino]-2-fluorophenyl]piperidin-1-yl]methyl]phenyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl]-2-methylphenyl]methyl]-1,2,4-oxadiazole-3-carboxamide.
| Compound Name | 5-tert-butyl-N-[[4-[6-[4-[[4-[4-[(2,6-dioxopiperidin-3-yl)amino]-2-fluorophenyl]piperidin-1-yl]methyl]phenyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl]-2-methylphenyl]methyl]-1,2,4-oxadiazole-3-carboxamide |
|---|---|
| PubChem CID | 174216451 |
| Molecular Formula | C44H46FN9O4 |
| Molecular Weight | 783.91 g/mol |
| Exact Mass | 783.37 |
| IUPAC Name | 5-tert-butyl-N-[[4-[6-[4-[[4-[4-[(2,6-dioxopiperidin-3-yl)amino]-2-fluorophenyl]piperidin-1-yl]methyl]phenyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl]-2-methylphenyl]methyl]-1,2,4-oxadiazole-3-carboxamide |
| SMILES | Cc1cc(-c2ncnn3cc(-c4ccc(CN5CCC(c6ccc(NC7CCC(=O)NC7=O)cc6F)CC5)cc4)cc23)ccc1CNC(=O)c1noc(C(C)(C)C)n1 |
| InChI | InChI=1S/C44H46FN9O4/c1-26-19-30(9-10-31(26)22-46-42(57)40-51-43(58-52-40)44(2,3)4)39-37-20-32(24-54(37)48-25-47-39)28-7-5-27(6-8-28)23-53-17-15-29(16-18-53)34-12-11-33(21-35(34)45)49-36-13-14-38(55)50-41(36)56/h5-12,19-21,24-25,29,36,49H,13-18,22-23H2,1-4H3,(H,46,57)(H,50,55,56) |
| InChIKey | CDKIHJHAHWNNFI-UHFFFAOYSA-N |
| XLogP | 6.72 |
| TPSA | 159.65 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 58 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 783.91 |
| LogP ≤ 5 | 6.72 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 11 |
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|